Sean P. Grant's most recent trade in Vera Therapeutics Inc - Ordinary Shares - Class A was a trade of 50,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 25,000 | 119,130 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 53,800 | 53,800 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 26,900 | 93,237 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 99,828 | 80,172 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.87 per share. | 03 Apr 2024 | 99,828 | 166,165 | - | 14.9 | 1,484,442 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.05 per share. | 03 Apr 2024 | 69,831 | 96,334 | - | 40.1 | 2,796,801 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.12 per share. | 03 Apr 2024 | 11,648 | 73,698 | - | 38.1 | 444,080 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.65 per share. | 03 Apr 2024 | 10,988 | 85,346 | - | 38.7 | 424,708 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.25 per share. | 03 Apr 2024 | 7,361 | 66,337 | - | 39.3 | 288,927 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.06 per share. | 03 Apr 2024 | 6,965 | 5,000 | - | 40.1 | 278,997 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.22 per share. | 03 Apr 2024 | 3,112 | 14,909 | - | 38.2 | 118,950 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.19 per share. | 03 Apr 2024 | 2,944 | 11,965 | - | 39.2 | 115,384 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.06 per share. | 03 Apr 2024 | 1,505 | 0 | - | 40.1 | 60,286 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.06 per share. | 03 Apr 2024 | 867 | 0 | - | 40.1 | 34,731 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.22 per share. | 03 Apr 2024 | 672 | 2,144 | - | 38.2 | 25,686 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.19 per share. | 03 Apr 2024 | 639 | 1,505 | - | 39.2 | 25,044 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.05 per share. | 03 Apr 2024 | 453 | 0 | - | 40.1 | 18,144 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.22 per share. | 03 Apr 2024 | 387 | 1,233 | - | 38.2 | 14,793 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.19 per share. | 03 Apr 2024 | 366 | 867 | - | 39.2 | 14,342 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.20 per share. | 03 Apr 2024 | 203 | 453 | - | 39.2 | 7,957 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.23 per share. | 03 Apr 2024 | 201 | 656 | - | 38.2 | 7,684 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.06 per share. | 03 Apr 2024 | 177 | 0 | - | 40.1 | 7,090 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.21 per share. | 03 Apr 2024 | 80 | 177 | - | 39.2 | 3,137 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.19 per share. | 03 Apr 2024 | 78 | 257 | - | 38.2 | 2,979 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 97,500 | 97,500 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | P. Grant Sean | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 26,250 | 78,683 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 16.60 per share. | 23 Jun 2023 | 5,000 | 5,992 | - | 16.6 | 83,000 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2023 | 14,285 | 35,648 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2023 | 14,285 | 15,277 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2023 | 1,620 | 18,657 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2023 | 1,620 | 1,620 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2023 | 636 | 18,021 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.00 per share. | 06 Feb 2023 | 14,285 | 49,933 | - | 7 | 99,995 | Class A Common Stock |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2022 | 33,750 | 35,268 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc (Class A) | Sean P. Grant | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 90,000 | 90,000 | - | - | Stock Option (right to buy) |